Single Use Gene Therapy Approved in the EU for Leber’s Congenital Amaurosis
Free-Photos / Pixabay

Single Use Gene Therapy Approved in the EU for Leber’s Congenital Amaurosis

According to a story from pm360online.com, the drug developer Novartis has recently announced that the company's gene therapy Luxturna has gained approval in the EU as a treatment for Leber's…

Continue Reading Single Use Gene Therapy Approved in the EU for Leber’s Congenital Amaurosis
Survivors of Head and Neck Squamous Cell Carcinoma Have Increased Risk of Suicide
Source: Pixabay

Survivors of Head and Neck Squamous Cell Carcinoma Have Increased Risk of Suicide

The following story includes discussion of suicide. According to a story from EurekAlert!, a recent study has revealed that survivors of head and neck cancer are four times more likely…

Continue Reading Survivors of Head and Neck Squamous Cell Carcinoma Have Increased Risk of Suicide
Managing Hyperkalemia in Cardiorenal Patients Taking RAAS Inhibitors
source: pixabay.com

Managing Hyperkalemia in Cardiorenal Patients Taking RAAS Inhibitors

According to a story from The British Journal of Cardiology, the use of renin-angiotensin-aldosterone-system (RAAS) inhibitors or blockers is a valuable component of treatment for many medical conditions and diseases,…

Continue Reading Managing Hyperkalemia in Cardiorenal Patients Taking RAAS Inhibitors
A Failed Drug Could Now be Used to Treat Inflammatory Bowel Disease?
Source: Pixabay.com

A Failed Drug Could Now be Used to Treat Inflammatory Bowel Disease?

In 2013 researchers discovered something interesting about the protein BH4. They found that by inhibiting the protein they could reduce patient's pain. A drug was created called Quartet, and it…

Continue Reading A Failed Drug Could Now be Used to Treat Inflammatory Bowel Disease?
FDA Approves Pfizer’s Acute Myeloid Leukemia Treatment for High-Risk Patients
Source: https://pixabay.com/en/thumb-up-like-sign-hand-ok-good-441938/

FDA Approves Pfizer’s Acute Myeloid Leukemia Treatment for High-Risk Patients

According to a publication from MarketScreener, pharmaceutical titan Pfizer Inc. has gained FDA approval for Daurismo, a once-a-day oral medication designed to be paired with low-dose cytarabine (a type of…

Continue Reading FDA Approves Pfizer’s Acute Myeloid Leukemia Treatment for High-Risk Patients
LEO Pharma Funds PellePharm’s Phase 3 Trial of Promising Gorlin Syndrome Drug
Source: pixabay.com

LEO Pharma Funds PellePharm’s Phase 3 Trial of Promising Gorlin Syndrome Drug

According to an article published by CheckOrphan, LEO Pharma and PellePharm have announced a new multi-million dollar partnership together with the aim of advancing research for rare skin diseases that…

Continue Reading LEO Pharma Funds PellePharm’s Phase 3 Trial of Promising Gorlin Syndrome Drug
Close Menu